Contact
searchSearch
HMP Global

APP Institute Inflammatory Bowel Disease

Featured

Marita Kametas
Rapid Refresh
Marita Kametas, MSN, on Disease Severity vs Activity in Crohn's Disease
04/21/2025
APP Marita Kametas, MSN, from the University of Chicago, provides an overview of disease severity and disease activity in Crohn's disease.
APP Marita Kametas, MSN, from the University of Chicago, provides an overview of disease severity and disease activity in Crohn's disease.
APP Marita Kametas, MSN, from...
04/21/2025
APP Institute Inflammatory Bowel Disease
Rapid Refresh
Marita Kametas, MSN, on Disease Severity vs Activity in Crohn's Disease
04/21/2025
APP Marita Kametas, MSN, from the University of Chicago, provides an overview of disease severity and disease activity in Crohn's disease.
APP Marita Kametas, MSN, from the University of Chicago, provides an overview of disease severity and disease activity in Crohn's disease.
APP Marita Kametas, MSN, from...
04/21/2025
APP Institute Inflammatory Bowel Disease
Clinical Pearls
Scoping Out the Issues in Crohn's Disease
04/18/2025
At the inaugural APP Institute Inflammatory Bowel Disease, IBD specialist APPs Kimberly Kearns, Kim Orleck, Abigail Meyers, and Angelia Collins presented a case study illustrating the challenges of diagnosing and treating Crohn's disease.
At the inaugural APP Institute Inflammatory Bowel Disease, IBD specialist APPs Kimberly Kearns, Kim Orleck, Abigail Meyers, and Angelia Collins presented a case study illustrating the challenges of diagnosing and treating Crohn's disease.
At the inaugural APP Institute...
04/18/2025
APP Institute Inflammatory Bowel Disease
Clinical Pearls
Scoping Out the Issues in Crohn's Disease
04/18/2025
At the inaugural APP Institute Inflammatory Bowel Disease, IBD specialist APPs Kimberly Kearns, Kim Orleck, Abigail Meyers, and Angelina Collins presented a case study illustrating the challenges of diagnosing and treating Crohn's disease.
At the inaugural APP Institute Inflammatory Bowel Disease, IBD specialist APPs Kimberly Kearns, Kim Orleck, Abigail Meyers, and Angelina Collins presented a case study illustrating the challenges of diagnosing and treating Crohn's disease.
At the inaugural APP Institute...
04/18/2025
APP Institute Inflammatory Bowel Disease
Jim Lewis
Clinical Pearls
James Lewis, MD, on Diet and Nutrition in Crohn's Disease
04/11/2025
James D. Lewis
Dr James Lewis recaps his presentation on using diet —including the Crohn's Disease Exclusion Diet, the Low FODmap Diet, and the Mediterranean diet—as an adjunct to medical therapy for Crohn's disease, and the potential for diet to perhaps...
Dr James Lewis recaps his presentation on using diet —including the Crohn's Disease Exclusion Diet, the Low FODmap Diet, and the Mediterranean diet—as an adjunct to medical therapy for Crohn's disease, and the potential for diet to perhaps...
Dr James Lewis recaps his...
04/11/2025
APP Institute Inflammatory Bowel Disease
Marla Dubinsky
Clinical Pearls
Marla Dubinsky, MD, on Risk Stratification in Crohn's Disease
04/11/2025
Marla C. Dubinsky, MD
Dr Dubinsky stresses that virtually all patients with Crohn's disease should be treated quickly after diagnosis with approved and effective therapies—which do not include 5-ASAs— to help prevent complications and change the natural history of...
Dr Dubinsky stresses that virtually all patients with Crohn's disease should be treated quickly after diagnosis with approved and effective therapies—which do not include 5-ASAs— to help prevent complications and change the natural history of...
Dr Dubinsky stresses that...
04/11/2025
APP Institute Inflammatory Bowel Disease
Sara Horst
Video
Sara Horst, MD, on Treatment Options for IBD in 2025
04/10/2025
Sara Horst, MD
Dr Sara Horst opened the AIBD regional meeting in Nashville with a comprehensive review of the many treatment options now available for inflammatory bowel disease and how to consider positioning them in a therapeutic plan.
Dr Sara Horst opened the AIBD regional meeting in Nashville with a comprehensive review of the many treatment options now available for inflammatory bowel disease and how to consider positioning them in a therapeutic plan.
Dr Sara Horst opened the AIBD...
04/10/2025
Advances in Inflammatory Bowel Disease Network
From Advances in Inflammatory Bowel Disease Network
David Rubin
Clinical Pearls
David Rubin, MD, on the GALAXI 2 and 3 Trials of Guselkumab in Crohn's Disease
04/09/2025
Dr Rubin reviews the results of phase 3 trials of guselkumab for treatment of Crohn's disease among patients who are bionaive, bioexposed, and biointolerant or who failed to respond to biologics. 
Dr Rubin reviews the results of phase 3 trials of guselkumab for treatment of Crohn's disease among patients who are bionaive, bioexposed, and biointolerant or who failed to respond to biologics. 
Dr Rubin reviews the results of...
04/09/2025
APP Institute Inflammatory Bowel Disease
FDA Alert
FDA Approves Both SC and IV Guselkumab for Crohn's Disease Among Adult Patients
03/24/2025
Rebecca Mashaw
This clearance follows last year's approval for ulcerative colitis and the first approval for subcutaneous and intravenous formulations to induce remission in adult patients with moderately to severely active Crohn's disease.
This clearance follows last year's approval for ulcerative colitis and the first approval for subcutaneous and intravenous formulations to induce remission in adult patients with moderately to severely active Crohn's disease.
This clearance follows last...
03/24/2025
Advances in Inflammatory Bowel Disease Network
From Advances in Inflammatory Bowel Disease Network
Erin Darguzas
APP Perspectives
The APP-MD Relationship
03/14/2025
Erin Darguzas, APN, from Northwestern Medicine in Chicago reviews how physician training culture and expectations are very different from APP training and onboarding and how this can affect expectations and the way APPs are incorporated into...
Erin Darguzas, APN, from Northwestern Medicine in Chicago reviews how physician training culture and expectations are very different from APP training and onboarding and how this can affect expectations and the way APPs are incorporated into...
Erin Darguzas, APN, from...
03/14/2025
APP Institute Inflammatory Bowel Disease
Clinical Pearls
Drs Miguel Regueiro and Corey Siegel Debate: Do All Patients With Crohn's Disease Need Advanced Therapy?
12/10/2024
The annual debate between Drs Regueiro and Siegel this year took on the topic of whether all patients newly diagnosed with Crohn's disease should be treated with advanced therapies from the beginning. Check out the video to see what each had...
The annual debate between Drs Regueiro and Siegel this year took on the topic of whether all patients newly diagnosed with Crohn's disease should be treated with advanced therapies from the beginning. Check out the video to see what each had...
The annual debate between Drs...
12/10/2024
APP Institute Inflammatory Bowel Disease

Clinical Pearls

Jim Lewis
Clinical Pearls
James Lewis, MD, on Diet and Nutrition in Crohn's Disease
04/11/2025
James D. Lewis
Dr James Lewis recaps his presentation on using diet —including the Crohn's Disease Exclusion Diet, the Low FODmap Diet, and the Mediterranean diet—as an adjunct to medical therapy for Crohn's disease, and the potential for diet to perhaps...
Dr James Lewis recaps his presentation on using diet —including the Crohn's Disease Exclusion Diet, the Low FODmap Diet, and the Mediterranean diet—as an adjunct to medical therapy for Crohn's disease, and the potential for diet to perhaps...
Dr James Lewis recaps his...
04/11/2025
APP Institute Inflammatory Bowel Disease
Marla Dubinsky
Clinical Pearls
Marla Dubinsky, MD, on Risk Stratification in Crohn's Disease
04/11/2025
Marla C. Dubinsky, MD
Dr Dubinsky stresses that virtually all patients with Crohn's disease should be treated quickly after diagnosis with approved and effective therapies—which do not include 5-ASAs— to help prevent complications and change the natural history of...
Dr Dubinsky stresses that virtually all patients with Crohn's disease should be treated quickly after diagnosis with approved and effective therapies—which do not include 5-ASAs— to help prevent complications and change the natural history of...
Dr Dubinsky stresses that...
04/11/2025
APP Institute Inflammatory Bowel Disease
David Rubin
Clinical Pearls
David Rubin, MD, on the GALAXI 2 and 3 Trials of Guselkumab in Crohn's Disease
04/09/2025
Dr Rubin reviews the results of phase 3 trials of guselkumab for treatment of Crohn's disease among patients who are bionaive, bioexposed, and biointolerant or who failed to respond to biologics. 
Dr Rubin reviews the results of phase 3 trials of guselkumab for treatment of Crohn's disease among patients who are bionaive, bioexposed, and biointolerant or who failed to respond to biologics. 
Dr Rubin reviews the results of...
04/09/2025
APP Institute Inflammatory Bowel Disease
Uma Mahadevan, MD
Clinical Pearls
Caring for the Pregnant Patient With IBD
02/26/2024
Uma Mahadevan
Dr Uma Mahadevan discusses the key factors to consider when caring for patients with inflammatory bowel disease who are or who want to become pregnant.
Dr Uma Mahadevan discusses the key factors to consider when caring for patients with inflammatory bowel disease who are or who want to become pregnant.
Dr Uma Mahadevan discusses the...
02/26/2024
APP Institute Inflammatory Bowel Disease
David Rubin
Clinical Pearls
Dose Optimization of Anti-TNF Therapy for IBD
02/26/2024
Dr David Rubin provides a guideline for optimizing adalimumab and infliximab in treating patients with inflammatory bowel disease.
Dr David Rubin provides a guideline for optimizing adalimumab and infliximab in treating patients with inflammatory bowel disease.
Dr David Rubin provides a...
02/26/2024
APP Institute Inflammatory Bowel Disease
Laura Raffals
Clinical Pearls
Top Clinical Pearls for Managing Ulcerative Colitis
01/21/2023
Dr Laura Raffals from Mayo Clinic discusses her top clinical tips for ensuring proper diagnosis, treatment, monitoring, and management of patients with ulcerative colitis.
Dr Laura Raffals from Mayo Clinic discusses her top clinical tips for ensuring proper diagnosis, treatment, monitoring, and management of patients with ulcerative colitis.
Dr Laura Raffals from Mayo...
01/21/2023
APP Institute Inflammatory Bowel Disease

APP Perspectives

Erin Darguzas
APP Perspectives
The APP-MD Relationship
03/14/2025
Erin Darguzas, APN, from Northwestern Medicine in Chicago reviews how physician training culture and expectations are very different from APP training and onboarding and how this can affect expectations and the way APPs are incorporated into...
Erin Darguzas, APN, from Northwestern Medicine in Chicago reviews how physician training culture and expectations are very different from APP training and onboarding and how this can affect expectations and the way APPs are incorporated into...
Erin Darguzas, APN, from...
03/14/2025
APP Institute Inflammatory Bowel Disease
Marita Kametas
APP Perspectives
Welcome to the APP Institute Inflammatory Bowel Disease!
03/01/2024
Marita Kametas, MSN, APN, introduces the new APP Institute Inflammatory Bowel DIsease and gives a brief overview of the content offerings for advanced practice providers in the IBD field.
Marita Kametas, MSN, APN, introduces the new APP Institute Inflammatory Bowel DIsease and gives a brief overview of the content offerings for advanced practice providers in the IBD field.
Marita Kametas, MSN, APN,...
03/01/2024
APP Institute Inflammatory Bowel Disease
Kim Orleck
APP Perspectives
Tracking Productivity in IBD Care for APPs
02/26/2024
Kimberly Orleck reviews how much of an APP's work in an IBD practice may not be carefully tracked or compensated for, and how to
Kimberly Orleck reviews how much of an APP's work in an IBD practice may not be carefully tracked or compensated for, and how to
Kimberly Orleck reviews how much...
02/26/2024
APP Institute Inflammatory Bowel Disease

Rapid Refresh

Kim Kearns
Video
Kimberly Kearns, MS, APRN, on Diagnostics in IBD
07/01/2024
Kimberly Kearns, MS, APN-BC, delves into the noninvasive and invasive diagnostic tools available to APPs working with patients who have or are suspected of having inflammatory bowel disease.
Kimberly Kearns, MS, APN-BC, delves into the noninvasive and invasive diagnostic tools available to APPs working with patients who have or are suspected of having inflammatory bowel disease.
Kimberly Kearns, MS, APN-BC,...
07/01/2024
APP Institute Inflammatory Bowel Disease
Marita Kametas
Rapid Refresh
Severity vs Activity in IBD
06/26/2024
Marita Kametas, MSN, APN, continues her tutorial on IBD with a review of the disease severity and disease activity, including how they differ and how they can be assessed.
Marita Kametas, MSN, APN, continues her tutorial on IBD with a review of the disease severity and disease activity, including how they differ and how they can be assessed.
Marita Kametas, MSN, APN,...
06/26/2024
APP Institute Inflammatory Bowel Disease
Marita Kametas
Rapid Refresh
UC or CD: What's the Difference?
06/26/2024
Marita Kametas, MSN, APN, from the University of Chicago, begins a series on the basics of inflammatory bowel disease, explaining the differences between ulcerative colitis and Crohn's disease.
Marita Kametas, MSN, APN, from the University of Chicago, begins a series on the basics of inflammatory bowel disease, explaining the differences between ulcerative colitis and Crohn's disease.
Marita Kametas, MSN, APN, from...
06/26/2024
APP Institute Inflammatory Bowel Disease

Visit Our Other APP Institutes

APP Institute Inflammatory Bowel Disease

 

The APP Institute is dedicated to educating and informing advanced practice providers on clinical topics and practical issues to support the profession and improve the quality of care for patients with inflammatory bowel disease.

The APP Institute | IBD is designed for Advanced Practice Providers who specialize in Inflammatory Bowel Diseases, to further their education and increase their knowledge to achieve better patient outcomes. Explore cutting-edge research, innovative treatment options, and new therapeutic methods, while remaining focused on the fundamental principles and terminology associated with IBD. Engage year-round with the AIBD Network to access clinical insights, interactive features, research news updates, accredited continuing education programs, and more.

 

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use